About kaleo
kaleo is a Healthcare company based in Richmond (United States) founded in 2005, and was acquired by Marathon Asset Management in November 2021. Auto-injector pharmaceutical products for medical emergencies are developed. The company has 220 employees. Its chief executive, as recorded, is Spencer Williamson. kaleo offers products and services including Aerioâ„¢ Auto-Injector Platform. Its focus areas include Life Sciences, Drug Delivery and Diversified. Its legal entity is kaleo, Inc. Its competitors include PharmaJet, Suono Bio and Renovis; 3 of its 3 listed competitors have raised funding.
Company details
Kaleo was founded in 2005 and is based in Richmond, United States. Auto-injector based pharmaceutical products are developed for use during medical emergencies, such as opioid overdose and allergic reactions. These products, including naloxone HCl injection and epinephrine autoinjector, are administered by patients or caretakers. Operations focus on the pharmaceutical sector, with emphasis on emergency response solutions.
- Headquarters Richmond, United States
- Employees 220
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website kaleo.com
- Social LinkedIn X Facebook
- Acquired by Marathon Asset Management (Nov 2021)
- Legal Name Kaleo, Inc
- Latest Funding Round$150M (USD), Debt – Conventional
Apr 2014
- InvestorsHercules Capital
& 2 more
- Employee Count220
- Acquired byMarathon Asset Management
(Nov 2021)
Products & Services of kaleo
kaleo offers a comprehensive portfolio of products and services, including Aerio™ Auto-Injector Platform.
Delivers medications via auto-injector for emergency patient care.
Funding Insights of kaleo
- Total Rounds 2
- Last Round Debt – Conventional — $150M
- First Round $15M
(May 2012)
- Investors Count 2
All 2 funding rounds of kaleo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2014 | $150M | Debt – Conventional | – | – | |
| May 2012 | $15M | Debt – Conventional | – | – |
3 investors in total: 3 institutional.
Investors in kaleo
kaleo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Hercules Capital, Marathon Asset Management and PDL BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biopharmaceutical company undergoing dissolution and asset distribution processes. | pdl.com | |||
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States | |
Diversified investment management services are provided across asset classes. | 1998 | marathonfund.com | New York, United States |
Investor details for kaleo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of kaleo
1 people are tracked at kaleo (1 in leadership); the tracked headcount is 220.
| Name | Role | Group |
|---|---|---|
Spencer Williamson | CEO & President | Leadership |
Complete people profiles for kaleo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of kaleo
4 dated milestones of kaleo across 16 years, from founding to its latest funding, stage changes and deals.
- Founded kaleo is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Debt – Conventional, of $150.0M.
- Exit Acquired by Marathon Asset Management.
Competitors of kaleo
kaleo has 3 listed competitors in our database, 3 of them funded. They include PharmaJet, Suono Bio and Renovis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmajet.com | 2005 | Golden, United States | $59.4M | 15 | Provider of needle-free injection technology | |
| suonobio.com | 2015 | Cambridge, United States | $12.68M | Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract | ||
| renovis.com | 2000 | San Francisco, United States | $45M | 368 | Drugs for neurological diseases are discovered and developed. |
Detailed competitors of kaleo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of kaleo
The website of kaleo (kaleo.com) receives about 4.4K visits a month and ranks #4,008,463 among all websites worldwide, #5,041 in Biotechnology and Pharmaceuticals.
- Monthly visits4.4K
▼ 5.5% vs previous month
- Unique visitors1.9K
per month
- Global rank#4,008,463
among all websites
- Category rank#5,041
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.7
- Average visit20 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with kaleo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| seppic.com | 100% | 55.4K | #686,675 | View details | |
knutsoncos.com | knutsoncos.com | 28% | #8,423,095 | – | |
officialkaleo.com | officialkaleo.com | 26% | #1,096,408 | – | |
| comstock.com | 24% | 6.2K | #3,455,800 | View details | |
| octaria.com | 24% | 4.3K | #4,569,066 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for kaleo
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as kaleo (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kaleo
Complete news archive for kaleo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about kaleo
kaleo was founded in 2005 and raised its 1st funding round 7 years after it was founded.
kaleo is headquartered in Richmond, United States. It is registered at Richmond, Virginia, United States.
Spencer Williamson is the CEO of kaleo, as recorded in our data.
kaleo has 220 employees.
Kaleo was founded in 2005 and is based in Richmond, United States. Auto-injector based pharmaceutical products are developed for use during medical emergencies, such as opioid overdose and allergic reactions. These products, including naloxone HCl injection and epinephrine autoinjector, are administered by patients or caretakers. Operations focus on the pharmaceutical sector, with emphasis on emergency response solutions.
kaleo offers Aerioâ„¢ Auto-Injector Platform.
kaleo has 3 investors. Key investors include Hercules Capital, Marathon Asset Management, and PDL BioPharma.
kaleo operates through Kaleo, Inc.
Yes. kaleo was acquired by Marathon Asset Management in November 2021.